[SaneVax: Despite the number of serious adverse reactions after HPV vaccinations in every country where they are launched, eight more underdeveloped countries have been targeted for HPV vaccine programs. Let’s hope the girls of Ghana, Laos, Madagascar, Malawi, Niger and Sierra Leone have access to the already proven safe and effective method of controlling cervical cancer – pap tests. After all, these tests are required for cervical cancer control despite vaccination status.]
Cancer vaccines for Kenya and Tanzania girls
By Christabel Ligami, special correspondent
Kenya and Tanzania are among the first eight countries in Africa and Asia that will receive funding for cervical cancer vaccines to help protect more than 180,000 poor girls.
Merck and GlaxoSmithKline (GSK) will fund the first pilot projects for the Gardasil vaccine, which immunises against the human papillomavirus virus (HPV) — the cause of most cervical cancers. Other countries to benefit are Ghana, Laos, Madagascar, Malawi, Niger and Sierra Leone.
Cervical cancer kills 275,000 women each year, 85 per cent of them from poor countries.